carbostyril has been researched along with Osteoporosis, Postmenopausal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gautam, J; Khedgikar, V; Kumar, A; Kumar, M; Kushwaha, P; Modukuri, RK; Sashidhara, KV; Singh, D; Sridhar, B; Trivedi, R | 1 |
Chang, WY; Lau, TL; Long, YO; López, FJ; Marschke, KB; Martinborough, E; Negro-Vilar, A; Oeveren, Av; Rix, PJ; Shen, Y; Vajda, EG; Viveros, OH; Zhi, L | 1 |
2 other study(ies) available for carbostyril and Osteoporosis, Postmenopausal
Article | Year |
---|---|
Discovery of coumarin-dihydropyridine hybrids as bone anabolic agents.
Topics: Administration, Oral; Anabolic Agents; Animals; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Calcification, Physiologic; Cell Differentiation; Coumarins; Crystallography, X-Ray; Dihydropyridines; Female; Gene Expression; Humans; Mice; Osteoblasts; Osteogenesis; Osteoporosis, Postmenopausal; Ovariectomy; Quinolones; Structure-Activity Relationship | 2013 |
Substituted 6-(1-pyrrolidine)quinolin-2(1H)-ones as novel selective androgen receptor modulators.
Topics: Administration, Oral; Anabolic Agents; Androgen Receptor Antagonists; Androgens; Animals; Biological Availability; Bone Density Conservation Agents; Female; Humans; Hypogonadism; Male; Muscle, Skeletal; Organ Size; Osteoporosis, Postmenopausal; Prostate; Pyrrolidines; Quinolines; Quinolones; Rats; Stereoisomerism; Structure-Activity Relationship | 2007 |